Skip to main content
. 2021 Nov 14;28(6):4686–4701. doi: 10.3390/curroncol28060395
ICI immune checkpoint inhibitor
NSCLC non-small cell lung cancer
CI confidence intervals
VATS video assisted thoracoscopic surgery
RECIST response evaluation criteria in solid tumors
MPR major pathological response
pCR complete pathological response
PD-L1 programmed death-ligand 1